Purpose: To evaluate the effects of intravitreal aflibercept (IVA) on the number of microaneurysms and sizes of nonperfused areas (NPAs) in eyes with diabetic macular edema (DME).
Design: Interventional, prospective study.
Participants: Twenty-five eyes of 25 DME patients (average age, 64.